Sorrento Therapeutics Inc (SRNE)

[Moses1492]

All in all the conference R&D call was bullish just no big surprise funding announcement yet or accelerated testing progress already underway. I guess it was as expected so to speak with solid progress moving forward just not as fast as some like myself were expecting. The following are very bullish points I weighed most:
1) COVI-TRACE: EUA app imminent. Key point from the call: "collected the clinical data" for COVI-TRACE EUA, which is a big step ahead from previous call on "robust". Other key words we are familiar with: "Most sensitive test in the space", "game changer", "Many inquiry" from clients, "huge revenue", .
2) COVI-STIX: EUA app imminent. Key words from the call: can "test the asymptomatic and pre-symptomatic patients", which is "very sensitive test", "huge revenue".
3) COVI-2020: they are about to apply IND for COVI-2020. "50 or more time strength than STI-1499", "acting like the vaccine".
4) STI-1499: The challenge for recruiting the patients for STI-1499 is addressed, which will be resolved soon with only 33 patients involved. based on the the trend of the new infected patients in Penn.

We can expect many bullish news coming from COVI-TRACE, COVI-STIX, STI-1499, and STI-2020 in coming weeks and months. The price big down AH was caused by the shorts. No real sale from longs, because there is no bearish news in the call.